Open AccessPara-aortic lymph node involvement should not be a contraindication to resection of pancreatic ductal adenocarcinoma
Author(s) -
Rupaly Pandé,
Shafiq Chughtai,
Manish Ahuja,
Rachel Brown,
David Bartlett,
Bobby Dasari,
Ravi Marudanayagam,
Darius Mirza,
Keith Roberts,
John Isaac,
Robert P. Sutcliffe,
Nikolaos Chatzizacharias
Publication year - 2022
Publication title -
world journal of gastrointestinal surgery
Language(s) - English
Resource type - Journals
ISSN - 1948-9366
DOI - 10.4240/wjgs.v14.i5.429
Subject(s) - medicine , lymph node , lymphadenectomy , contraindication , lymph , retrospective cohort study , pancreatic cancer , proportional hazards model , surgery , cancer , pathology , alternative medicine
Para-aortic lymph nodes (PALN) are found in the aortocaval groove and they are staged as metastatic disease if involved by pancreatic ductal adenocarcinoma (PDAC). The data in the literature is conflicting with some studies having associated PALN involvement with poor prognosis, while others not sharing the same results. PALN resection is not included in the standard lymphadenectomy during pancreatic resections as per the International Study Group for Pancreatic Surgery and there is no consensus on the management of these cases.